For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...
Touch a hot plate and your hand flies back. While the response is almost instant, researchers are still working to better understand the molecular mechanisms behind these sensations of heat and pain.
The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...
A rare genetic variant found in families affected by schizophrenia completely abolishes the function of TAAR1, an emerging drug target for psychiatric disorders. The C182F mutation causes a 40% ...
ZÜRICH, SWITZERLAND / ACCESSWIRE / December 3, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (NLS), a biopharmaceutical company, is pleased to share preclinical data demonstrating the ...
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...
A deep dive into the scientific shift toward multi-target obesity therapeutics and its implications for metabolic health and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback